VRC Medical Services continues to expand its comparator sourcing capabilities to improve access to essential medications, strengthen clinical research continuity, and support long-term cost reduction across the U.S. healthcare system.
Comparator sourcing plays a critical role in clinical research, particularly in biosimilar and generic drug development. Reliable access to reference products enables competition, supports regulatory progress, and contributes to broader patient access by placing downward pressure on drug pricing.
“Access to comparator drugs is foundational to competition in the pharmaceutical market,” said Stephen Corba, Director at VRC Medical Services and Chief Executive Officer of Investigational Drug Delivery (IDD) LLC. “When clinical trials are delayed or blocked due to sourcing challenges, patients ultimately absorb the cost through reduced competition and higher prices.”
Over the past 15 years, VRC Medical Services has focused on diversified procurement strategies designed to reduce dependency on single suppliers and mitigate shortages that disrupt research timelines. These sourcing frameworks support biosimilar development efforts that have collectively contributed to tens of billions of dollars in savings across the U.S. healthcare system through increased competition and lower-cost therapeutic alternatives.
Industry data indicates that biosimilar adoption and expanded comparator access have generated more than $38 billion in cumulative savings for U.S. healthcare payers and patients in recent years. VRC Medical Services supports this progress by ensuring clinical trials maintain continuity and meet regulatory requirements.
These efforts align with long-standing federal priorities focused on lowering prescription drug costs. Recent initiatives, including the Trump administration’s RX policy framework, emphasize competition and market access as essential drivers of affordability. Comparator availability remains one of the most critical—and often overlooked—components of that infrastructure.
In addition to comparator sourcing, VRC Medical Services supports compliance, regulatory documentation, and supply-chain transparency for clinical research organizations. The company has also contributed to safety-focused initiatives, including FDA-approved medical products currently used by hospitals nationwide.
Looking ahead, VRC Medical Services plans to continue expanding its sourcing network and technology-enabled tracking systems to support clinical trials that advance competition, affordability, and patient access to essential therapies.
“Our role is practical, not political,” Corba added. “When trials move forward efficiently, competition increases, costs come down, and patients benefit.”
About VRC Medical Services
VRC Medical Services is a specialty pharmaceutical distribution company focused on sourcing hard-to-access comparator and investigational medications for clinical trials. The company supports hospitals, research organizations, and Contract Research Organizations with reliable, compliant procurement solutions.
